USPTO serial 79041699
SIMCYP
Reviewed by CopyMark Law Group
Reg. 3449804Status 706Registered
- Filing date
- Status date
- Registration date
- Jun 17, 2008
- Examiner
- HOLTZ, ALLISON
- Law office
- GENERIC WEB UPDATE
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with SIMCYP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carrie Webb Olson
Carrie Webb Olson Day Pitney LLPOne Federal Street, 29th FloorBoston, MA 02110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer software, namely, computer software for the conducting of pharmacokinetic and pharmacodynamic simulations of medicines and their effect on the human body, computer software for utilising demographic, physiologic, and genomic databases for the creation and development of algorithms allowing researchers to take into account patient variability, computer software for the production of drug effects on a virtual patient population, computer software which allows pharmaceutical product developers to identify potential patients and groups of individuals which may be at extreme risk to adverse reaction to particular medicines or combinations; pharmaceutical analysis computer software; computer software that uses in vitro data from human tissues to predict metabolism, interactions and kinetic behaviour of drugs/chemicals in vivo (whole human) | ACTIVE | — |
| 042 | Scientific consultancy services in the field of pharmaceutical product development, pharmaceutical research, pharmaceutical drug research and development, virtual testing of new pharmaceutical drugs and products by means of computer simulation; scientific consultancy services employing pharmaceutical analysis software that uses in vitro data from human tissues to predict the metabolism, interactions, and kinetic behaviour of drugs/chemicals in vivo (whole human) | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 12, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 26, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 26, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 26, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jul 26, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 26, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 26, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 26, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 9, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 13, 2018 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jul 13, 2018 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jul 10, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 15, 2018 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 17, 2017 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 17, 2017 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jun 2, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 11, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 28, 2014 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 28, 2014 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 28, 2014 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 19, 2014 | 715F | REGISTERED - SEC. 71 & SEC. 15 FILED | — |
| Mar 19, 2014 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Dec 31, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 6, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 6, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 17, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 17, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 1, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 12, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 26, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 26, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jan 29, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 8, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 8, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 8, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 25, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 26, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 25, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 25, 2007 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 24, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 7, 2007 | NWAP | NEW APPLICATION ENTERED | — |
| Sep 6, 2007 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |